Skip to content

Effects of green light therapy on postoperative pain and quality of recovery in patients undergoing thoracoscopic surgery: a prospective randomized controlled trial

Effects of green light therapy on postoperative pain and quality of recovery in patients undergoing thoracoscopic surgery: a prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127951
Enrollment
Unknown
Registered
2026-07-10
Start date
2026-07-10
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Green Light group:Green Light Therapy
White light group:White light exposure (routine operating room illumination)

Sponsors

People's Hospital of Jianyang City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 18 and 80 years old. 2.Patients scheduled for elective thoracoscopic surgery; 3.American Society of Anesthesiologists (ASA) physical status ?–?; 4.Expected postoperative hospital stay >=72 hours; 5.Capable of understanding the numerical rating scale (NRS) and questionnaire items; 6.Provided written informed consent and volunteered to participate in this trial.

Exclusion criteria

Exclusion criteria: 1.Severe ocular diseases, including glaucoma, macular degeneration, cataract, retinopathy and history of ocular trauma; 2.Severe neurological diseases, including brain injury, stroke and neurodegenerative diseases; 3.History of psychiatric disorders, such as bipolar disorder and schizophrenia; 4.Long-term (>= 3 months) preoperative use of opioids; 5.Color blindness or color vision deficiency; 6.Photodermatoses, including lupus erythematosus, photosensitive dermatitis and other related conditions; 7.Pregnancy or lactation; 8.Preoperative score >= 11 on the anxiety or depression subscale of the HADS (indicating moderate to severe anxiety or depression); 9.Participation in other interventional clinical trials.

Design outcomes

Primary

MeasureTime frame
Numerical Rating Scale score;

Secondary

MeasureTime frame
Numerical Rating Scale score;The opioid consumption;Anxiety and depression;Emotional status;Numerical Rating Scale Score;Rescue analgesia;Postoperative length of hospital stay;The adverse events;The quality of recovery;

Countries

China

Contacts

Public ContactYan Weng

People's Hospital of Jianyang City

binglan_atropine@163.com+86 18228445816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026